Madeleine J Oudin

Parallel In Vivo Assessment of Drug Phenotypes at Various Time Points during Systemic BRAF Inhibition Reveals Tumor Adaptation and Altered Treatment Vulnerabilities

Robert Langer, Michael J Cima, Frank B Gertler, 2016, Clinical Cancer Research.

Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression.

Robert Langer, Michael J Cima, Douglas A Lauffenburger, 2016, Cancer discovery.

Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance.

Hakho Lee, Ralph Weissleder, Douglas A Lauffenburger, 2016, Cancer discovery.

Foxa2 and Cdx2 cooperate with Nkx2-1 to inhibit lung adenocarcinoma metastasis

Arjun Bhutkar, Frank B Gertler, T. Jacks, 2015, Genes & development.